000 | 01367 a2200373 4500 | ||
---|---|---|---|
005 | 20250512033507.0 | ||
264 | 0 | _c19890710 | |
008 | 198907s 0 0 eng d | ||
022 | _a0393-974X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChisesi, T | |
245 | 0 | 0 |
_aThe effect of thymic substances on T circulating cells of patients treated for Hodgkin's disease. _h[electronic resource] |
260 |
_bJournal of biological regulators and homeostatic agents _c |
||
300 |
_a193-8 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aHodgkin Disease _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukocyte Count _xdrug effects |
650 | 0 | 4 |
_aLymphopenia _xchemically induced |
650 | 0 | 4 |
_aPeptide Fragments _xpharmacology |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
650 | 0 | 4 | _aThymopentin |
650 | 0 | 4 |
_aThymopoietins _xpharmacology |
650 | 0 | 4 |
_aThymus Extracts _xpharmacology |
650 | 0 | 4 |
_aThymus Hormones _xpharmacology |
700 | 1 | _aCapnist, G | |
700 | 1 | _aRancan, L | |
700 | 1 | _aPellizzari, G | |
700 | 1 | _aVespignani, M | |
773 | 0 |
_tJournal of biological regulators and homeostatic agents _gvol. 2 _gno. 4 _gp. 193-8 |
|
999 |
_c3080443 _d3080443 |